Aroa Biosurgery Limited
AROAF
$0.35
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.93M | 13.45M | 11.97M | 11.85M | 11.39M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.93M | 13.45M | 11.97M | 11.85M | 11.39M |
| Cost of Revenue | 1.96M | 2.04M | 1.58M | 1.57M | 1.54M |
| Gross Profit | 10.97M | 11.41M | 10.39M | 10.28M | 9.85M |
| SG&A Expenses | 9.34M | 9.72M | 10.44M | 10.33M | 10.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -139.40K | -145.00K | -181.00K | -179.10K | -212.50K |
| Total Operating Expenses | 12.36M | 12.85M | 13.48M | 13.34M | 12.91M |
| Operating Income | 569.90K | 592.90K | -1.51M | -1.49M | -1.52M |
| Income Before Tax | -97.90K | -101.90K | -888.10K | -878.80K | -1.31M |
| Income Tax Expenses | 49.40K | 51.40K | 118.90K | 117.70K | 18.40K |
| Earnings from Continuing Operations | -147.30K | -153.30K | -1.01M | -996.50K | -1.32M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -147.30K | -153.30K | -1.01M | -996.50K | -1.32M |
| EBIT | 569.90K | 592.90K | -1.51M | -1.49M | -1.52M |
| EBITDA | 1.02M | 1.08M | -1.01M | -994.80K | -1.03M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 345.25M | 345.25M | 344.55M | 344.55M | 344.38M |
| Average Diluted Shares Outstanding | 345.25M | 345.25M | 344.55M | 344.55M | 344.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |